BioLineRx Ltd | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (44)

Latest Posts

About This Stock More About This Stock
Week In Review: Hengrui Out-Licenses Next-Gen PARP1 To Merck KGaA For $1.7 Billion
Article By: ChinaBio® Today
Saturday, November 4, 2023 3:00 PM EST
Jiangsu Hengrui Pharma out-licensed global rights for its next-gen PARP1 inhibitor to Germany’s Merck KGaA for a $170 million upfront payment and up to $1.5 billion in milestones. Merck will have rights to manufacture and commercialize the drug.
In this article: MKGAF, BLRX, CHRS, IVBXF, SHJBF Also: LLY
Read
Boris Bounce; Trump Tripwire
Article By: Vivian Lewis
Sunday, December 15, 2019 5:30 PM EST
Boris Johnson beat the pollsters handily and Britain went into holiday mode. Meanwhile back on Capitol Hill, the on-again-off-again trade deal with China was on again on. The drug price limits bill is dead in the water which will boost pharma stocks.
In this article: BLRX, LLY, RHHBY, EXEL, GSK, BVNRY, CZZ, IRL, MXE, NOK, SLB, MXCHF, NPSNY, TCEHY, HOLI, AQN, PROSY
Read
3 Small Cap Biotechs With Upcoming Catalysts
Article By: Scott Matusow
Monday, October 1, 2018 8:21 PM EST
Catalyst Trading in biotech stocks can be very profitable. Often times, many catalyst events are over looked by the market, especially when it comes to small cap biotech.
In this article: AFMD, BLRX, SNDX Also: BMY, FPRX
Read
Week In Review: Xynomic Signs $502 Million Deal For Boehringer's RAF Inhibitor
Article By: ChinaBio® Today
Saturday, November 4, 2017 4:58 PM EST
Xynomic Pharma, a US-Shanghai clinical-stage oncology drug developer, acquired exclusive global rights to a 2nd-generation RAF inhibitor from Boehringer Ingelheim. Xynomic, hoping BI 882370 is a best-in-class drug, agreed to a $502 million package.
In this article: BLRX, ILMN, TEVA, NAVB Also: INTC, BABA
Read
Trump's Kvittle
Article By: Vivian Lewis
Tuesday, May 23, 2017 12:24 AM EST
The President should not be blamed for all the fall in our currency, because even before he hit the scene the US$ was up way over trend, and near its 1985 peak. To revive industry, as Trump proposes, he needs a cheaper currency.
In this article: , ALV, CZZ, F, GSK, MXE, TTM, VALE, VOD, CH, ANCUF, AQUNF, BKSHF, CGRIF, CMDXF, DLKGF, NPSNY, OROCF, PPEHF, TCTZF, BLRX, SHPG, TEVA, CGEN, CUBA, INPCF, BNTC, BNTCW
Read

Latest Tweets for $BLRX

No tweets yet!

PARTNER HEADLINES

$BLRX

Another Bad Day For Stocks
David J. Williamson 10/21/2018 8:42:58 PM

I like $BLRX. What was the Gamida cell news that I missed?

1 to 1 of 1 comments